World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

ITGR INVESTOR ALERT: Integer Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead the Integer Holdings Class Action Lawsuit

WL Writing Staff by WL Writing Staff
December 12, 2025
in Press Releases
Reading Time: 5 mins read
0
Share on FacebookShare on Twitter

SAN DIEGO, Dec. 11, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers of Integer Holdings Corporation (NYSE: ITGR) common stock between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”), have until February 9, 2026 to seek appointment as lead plaintiff of the Integer Holdings class action lawsuit. Captioned West Palm Beach Firefighters’ Pension Fund v. Integer Holdings Corporation, No. 25-cv-10251 (S.D.N.Y.), the Integer Holdings class action lawsuit charges Integer Holdings and certain of Integer Holdings’ top executives and advisors with violations of the Securities Exchange Act of 1934.


Robbins Geller Rudman & Dowd LLP (PRNewsfoto/Robbins Geller Rudman & Dowd LLP)

If you suffered substantial losses and wish to serve as lead plaintiff of the Integer Holdings class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-integer-holdings-corporation-class-action-lawsuit-itgr.html 

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com.

CASE ALLEGATIONS: Integer Holdings operates as a medical device contract development and manufacturing company.

The Integer Holdings class action lawsuit alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Integer Holdings materially overstated its competitive position within the growing electrophysiology (“EP”) manufacturing market; (ii) despite Integer Holdings’ claims of strong visibility into customer demand, Integer Holdings was experiencing a sustained deterioration in sales relating to two of its EP devices; and (iii) in turn, Integer Holdings mischaracterized its EP devices as a long-term growth driver for its Cardio & Vascular segment.

The Integer Holdings class action lawsuit further alleges that on October 23, 2025, Integer Holdings disclosed that it had lowered its full-year 2025 sales guidance, which fell short of analysts’ estimates. Additionally, Integer Holdings informed investors that it expected net sales growth of -2% to 2% and organic sales growth of 0% and 4% for the full year of 2026, according to the complaint. Integer Holdings CEO, defendant Joseph W. Dziedzic, further allegedly stated that, “[w]hile select headwinds are expected to impact our 2026 sales, we believe our strategy and strong product development pipeline will lead to a return to 200 basis points above-market organic growth in 2027.” On this news, the price of Integer Holdings common stock fell more than 32%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Integer Holdings common stock during the Class Period to seek appointment as lead plaintiff in the Integer Holdings class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Integer Holdings investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Integer Holdings shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Integer Holdings class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 

Services may be performed by attorneys in any of our offices. 

Contact:

Robbins Geller Rudman & Dowd LLP

J.C. Sanchez, Jennifer N. Caringal

655 W. Broadway, Suite 1900, San Diego, CA 92101

800-449-4900

info@rgrdlaw.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/itgr-investor-alert-integer-holdings-corporation-investors-with-substantial-losses-have-opportunity-to-lead-the-integer-holdings-class-action-lawsuit-302639693.html

SOURCE Robbins Geller Rudman & Dowd LLP

WL Writing Staff

WL Writing Staff

Related Posts

35th Annual RSAC Conference Opens Flagship Event in San Francisco on Monday

March 23, 2026

Hemant Baidwan, Former Department of Homeland Security Chief Information Security Officer and Acting Deputy CIO, Joins Knox Systems

March 23, 2026

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis

March 23, 2026

Leading DC/Maryland Practice Expands Access to Premium, On-Demand Remote Pregnancy Monitoring with INVU™

March 23, 2026

Diversis Capital Acquires LTi Technology Solutions to Accelerate Innovation in Equipment Finance Technology

March 23, 2026

NICHOLAS AIR the Premium Private Air Travel Provider Upgrades Fleet In-Flight Connectivity with Starlink

March 23, 2026

Popular News

  • Hemant Baidwan, Former Department of Homeland Security Chief Information Security Officer and Acting Deputy CIO, Joins Knox Systems

    0 shares
    Share 0 Tweet 0
  • 35th Annual RSAC Conference Opens Flagship Event in San Francisco on Monday

    0 shares
    Share 0 Tweet 0
  • Leading DC/Maryland Practice Expands Access to Premium, On-Demand Remote Pregnancy Monitoring with INVU™

    0 shares
    Share 0 Tweet 0
  • EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis

    0 shares
    Share 0 Tweet 0
  • Diversis Capital Acquires LTi Technology Solutions to Accelerate Innovation in Equipment Finance Technology

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler